###begin article-title 0
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Tracing Functional Antigen-Specific CCR6+ Th17 Cells after Vaccination
###end article-title 0
###begin p 1
Conceived and designed the experiments: JP CB ET XP AMM DNM AL. Performed the experiments: JP CB ET XP AMM AL. Analyzed the data: JP CB ET XP AMM AL. Contributed reagents/materials/analysis tools: DNM AL. Wrote the paper: JP AMM AL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The function of T helper cell subsets in vivo depends on their location, and one hallmark of T cell differentiation is the sequential regulation of migration-inducing chemokine receptor expression. CC-chemokine receptor 6 (CCR6) is a trait of tissue-homing effector T cells and has recently been described as a receptor on T helper type 17 (Th17) cells. Th17 cells are associated with autoimmunity and the defence against certain infections. Although, the polarization of Th cells into Th17 cells has been studied extensively in vitro, the development of those cells during the physiological immune response is still elusive.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 350 351 350 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
We analysed the development and functionality of Th17 cells in immune-competent mice during an ongoing immune response. In naive and vaccinated animals CCR6+ Th cells produce IL-17. The robust homeostatic proliferation and the presence of activation markers on CCR6+ Th cells indicate their activated status. Vaccination induces antigen-specific CCR6+ Th17 cells that respond to in vitro re-stimulation with cytokine production and proliferation. Furthermore, depletion of CCR6+ Th cells from donor leukocytes prevents recipients from severe disease in experimental autoimmune encephalomyelitis, a model for multiple sclerosis in mice.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
In conclusion, we defined CCR6 as a specific marker for functional antigen-specific Th17 cells during the immune response. Since IL-17 production reaches the highest levels during the immediate early phase of the immune response and the activation of Th17 cells precedes the Th1 cell differentiation we tent to speculate that this particular Th cell subset may represent a first line effector Th cell subpopulation. Interference with the activation of this Th cell subtype provides an interesting strategy to prevent autoimmunity as well as to establish protective immunity against infections.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 148 151 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Mosmann1">[1]</xref>
###xml 240 243 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Levings1">[2]</xref>
###xml 757 760 750 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Happel1">[3]</xref>
###xml 761 764 754 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Murphy1">[6]</xref>
###xml 998 1001 991 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Langrish1">[7]</xref>
###xml 1003 1006 996 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Harrington1">[8]</xref>
###xml 1075 1078 1068 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Veldhoen1">[9]</xref>
###xml 1178 1181 1168 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Veldhoen1">[9]</xref>
###xml 1182 1186 1172 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Bettelli1">[11]</xref>
###xml 1289 1293 1279 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-AbdollahiRoodsaz1">[12]</xref>
###xml 1295 1299 1285 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-vanBeelen1">[13]</xref>
###xml 1542 1545 1532 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Harrington1">[8]</xref>
###xml 1547 1551 1537 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Bogdan1">[14]</xref>
###xml 1839 1843 1829 1833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-AcostaRodriguez1">[15]</xref>
###xml 1845 1849 1835 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Hirota1">[16]</xref>
###xml 2220 2221 2210 2211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2605 2606 2595 2596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2757 2758 2747 2748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2815 2816 2805 2806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1100 1104 <span type="species:ncbi:10090">mice</span>
###xml 2065 2069 <span type="species:ncbi:10090">mice</span>
###xml 2260 2264 <span type="species:ncbi:10090">mice</span>
In the late 80ies Mossman et al. designated Th1 and Th2 cells according to their capacity to secrete the cytokines IFN-gamma and IL-4, respectively [1]. Since then, IL-10 and TGF-beta producing T cells were identified as regulatory T cells [2]. The increasing knowledge about the heterogeneity of the Th cell subpopulations helped to explain how most infections are resolved. Nevertheless, the involvement of Th cells in the elimination of extracellular bacteria and fungi, and in the development of autoimmune disorders could not be adequately explained with the T effector cell subpopulations as defined in the literature so far. Recent studies on the role of the APC-derived cytokine IL-23 for the development of autoimmunity and clearance of infections [3]-[6] expanded our knowledge in T cell immunology by pointing to a new Th cell subtype involved in these mechanisms. These particular Th cells are characterised by the production of the cytokine IL-17 and are now referred to as Th17 cells [7], [8]. While the expansion and maintenance of Th17 cells depends on IL-23 [9], their generation in mice is induced by the early inflammatory cytokines IL-21, IL-6, and TGF-beta [9]-[11]. These cytokines are produced early in the inflammatory process by innate effector cells and Th cells [12], [13]. Once the Th cells are differentiated, the cytokine milieu influences the functionality of each of the Th cell subsets; Thl, Th2, and Th17 cells produce cross-regulatory cytokines that are mutually inhibitory for the respective other subsets [8], [14]. Nevertheless, it is still unclear how the development and maintenance of Th17 cells is regulated during the immune response in vivo. One of the reasons for this is the lack of well-characterised surface markers identifying Th17 cells. Based on the findings that Th17 cells express CCR6 [15], [16] we examined the generation of IL-17 producing Th cells in a non-infectious vaccination model with ovalbumin (OVA), and analysed the functionality of Th17 cells during the immune response in immune-competent C57BL/6 mice. For the first time, we demonstrated that CCR6 is a selective marker for the identification of Th17 cells during an immune response. Furthermore, CCR6+ Th17 cells were present even in naive mice and this population showed signs of activation in the steady state. During the acute phase of the immune response, the proportion of IL-17 producing Th cells in the lymph nodes decreased compared to the Th1 cell subpopulation. Nevertheless, antigen-specific IL-17 producing responder cells arose in the lymph node. The functionality of CCR6+ Th17 cells was demonstrated in adoptively transferred experimental autoimmune encephalomyelitis (at-EAE); transfer of lymph node cells containing CCR6+ Th17 cells led to severe disease while depletion of CCR6+ Th cells attenuated the course of at-EAE.
###end p 9
###begin title 10
Materials and Methods
###end title 10
###begin title 11
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 11
###begin p 12
###xml 386 390 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Bauer1">[17]</xref>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">Mice</span>
Inbred C57BL/6 mice were purchased from Charles River (Sulzfeld, Germany), inbred SJL/J mice were obtained from Harlan Winkelmann (Borchen, Germany). OVA TCR transgenic (OT-II) mice were bred and maintained in the animal facilities of the University of Regensburg. Mice of 8-16 weeks of age were used. Vaccination with OVA was performed injecting 100 microg OVA and 8 nmol CpG-ODN 1668 [17] s.c. into the hind footpad. All experiments were conducted according to animal experimental ethics committee guidelines and were approved by the local authorities.
###end p 12
###begin title 13
Antibodies and reagents
###end title 13
###begin p 14
###xml 55 58 <span type="species:ncbi:10116">Rat</span>
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
###xml 89 92 <span type="species:ncbi:10116">rat</span>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 129 132 <span type="species:ncbi:10116">rat</span>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
###xml 162 165 <span type="species:ncbi:10116">rat</span>
###xml 171 176 <span type="species:ncbi:10090">mouse</span>
###xml 212 217 <span type="species:ncbi:10090">mouse</span>
###xml 239 242 <span type="species:ncbi:10116">rat</span>
###xml 248 253 <span type="species:ncbi:10090">mouse</span>
###xml 280 283 <span type="species:ncbi:10116">rat</span>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 480 483 <span type="species:ncbi:10116">Rat</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
The following antibodies were used for flow cytometry: Rat anti-mouse CD4 (clone RM4-5), rat anti-mouse CD8alpha (clone 53-6.7), rat anti-mouse CD44 (clone IM7), rat anti-mouse CD62L (clone MEL-14), hamster anti-mouse CD69 (clone H1.2F3), rat anti-mouse IFN-gamma (clone XMG1.2), rat anti-mouse IL-17 (clone TC11-18H10.1), mouse anti-BrdU (clone B44), PE and APC labelled isotype control IgG. All mAb and isotype controls were purchased from BD Biosciences (Heidelberg, Germany). Rat anti-mouse CCR6 (clone 140706) was purchased from R&D Systems (Wiesbaden, Germany). Hamster anti-mouse CD3epsilon (clone 145.2C11) was purified from hybridoma cell culture supernatant using protein-G-sepharose columns (GE Healthcare, Munchen, Germany).
###end p 14
###begin title 15
Flow cytometry and cell sorting
###end title 15
###begin p 16
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Lechner1">[18]</xref>
###xml 471 472 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 618 619 618 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 624 625 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 642 643 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 567 572 <span type="species:ncbi:10090">mouse</span>
Popliteal and inguinal lymph nodes were harvested. Single cell suspension was prepared as previously described [18]. Cells were incubated with the appropriate antibodies in staining buffer (PBS containing 2% FCS). Data was collected on the LSR II flow cytometer (BD Biosciences) and analysed using the DIVA software (BD Biosciences). All staining profiles were based on live-gated cells, as determined by forward and sideward scatter properties. For the separation of CD4+ T cells the MACS system (Miltenyi Biotec, Bergisch Gladbach, Germany) was employed using anti-mouse CD4 MACS beads. For further separation of CD4+ CCR6+ lymphocytes 5x107 cells per sample were incubated in 500 microl of staining buffer with the appropriate antibodies. Cells were sorted on the FACSAria cell sorter (BD Biosciences).
###end p 16
###begin title 17
Analysis of cell proliferation in vitro
###end title 17
###begin p 18
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Lymph node cells (5x105) were labelled with CFSE (Invitrogen, Karlsruhe, Germany) at a final concentration of 1.25 microM, and cultured in 200 microl RPMI 1640 (PAN Biotech, Aidenbach, Germany) supplemented with 10% FCS (Sigma-Aldrich, Munchen, Germany), 50 microM beta-mercaptoethanol, 2 mM L-glutamine, 100 U/ml penicillin and 100 microg/ml streptomycin (PAN Biotech). Cells were stimulated with OVA (20 microg/ml; Sigma-Aldrich) or plate bound anti-CD3 (5 microg/ml) and proliferation was assessed by flow cytometry.
###end p 18
###begin title 19
Measurement of cell proliferation in vivo
###end title 19
###begin p 20
###xml 554 555 550 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 560 561 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 568 569 564 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 574 575 570 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 449 454 <span type="species:ncbi:10090">mouse</span>
OT-II mice were immunised for the indicated periods of time and fed with 5-Bromo-2'-deoxyuridine (BrdU; 800 microg/ml) in drinking water for three days. Draining lymph nodes were harvested and single cell suspensions were prepared. Cell surface staining was performed. The detection of the incorporated BrdU was conducted with the BrdU Flow Kit (BD Biosciences) according to the manufacturer's instructions with the exception that a FITC-conjugated mouse anti-BrdU (clone B44) was used for detection of the thymidine analogue. Proliferation of either CD4+ CCR6+ or CD4+ CCR6- cells was assessed by the presence of BrdU fluorescence in dividing cells.
###end p 20
###begin title 21
Determination of cytokine production
###end title 21
###begin p 22
Cells were stimulated with plate bound anti-CD3 (5 microg/ml) or OVA (20 microg/ml) in vitro and supernatants were collected. IFN-gamma and IL-17A protein quantification was performed with DUO-ELISA kits (R&D Systems) following the manufacturer's instructions. The detection limit for IFN-gamma and for IL-17A was 20 pg/ml.
###end p 22
###begin title 23
Intracellular cytokine staining
###end title 23
###begin p 24
Freshly isolated or in vitro reactivated lymph node cells were stimulated with ionomycin (1 microM; Sigma-Aldrich), and PMA (80 ng/ml; Sigma-Aldrich) in the presence of GolgiStop (BD Biosciences) for 4 h. Intracellular staining was performed using the Cytofix/Cytoperm Kit (BD Biosciences) according to the manufacturer's instructions.
###end p 24
###begin title 25
Induction and assessment of at-EAE
###end title 25
###begin p 26
###xml 410 411 402 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 416 417 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 422 423 414 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 431 432 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 437 438 429 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 526 527 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 532 533 524 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 762 763 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 56 62 <span type="species:ncbi:10090">murine</span>
###xml 148 151 <span type="species:ncbi:31658">CFA</span>
###xml 227 253 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 741 746 <span type="species:ncbi:10090">mouse</span>
SJL/J mice were immunised by injection of 200 microg of murine PLP (aa139-151, Pepceuticals Limited, UK), emulsified in Complete Freund's adjuvant (CFA) (Difco Laboratories, Detroit, Michigan, USA) supplemented with 500 microg Mycobacterium tuberculosis (Difco Laboratories). After 10 days cells were harvested from draining lymph nodes and single cell suspension was prepared. Lymphocytes were sorted into CD4-, CD4+ CCR6- and CD4+ CCR6+ fractions. After the sorting procedure cell fractions either including or excluding CD4+ CCR6+ cells were combined in the same ratio as present in the starting lymph nodes and cultured with 5 microg/ml PLP for 72 h. Afterwards, lymph node cells were harvested and washed twice with PBS. Each recipient mouse received 3.5x106 activated lymph node cells by i.p. injection. Weight and clinical score were recorded at the indicated time points according to the following criteria: 0 = healthy; 1 = limp tail; 2 = partial hindlimb weakness and/or ataxia; 3 = complete paralysis of at least one hindlimb; 4 = severe forelimb weakness; 5 = moribund or dead.
###end p 26
###begin title 27
Statistical analysis
###end title 27
###begin p 28
Error bars represent SEM. For statistical analysis two-tailed Student's t test was used unless indicated otherwise; p<0.05 was considered significant. For at-EAE experiments differences were analyzed by the non-parametric Mann-Whitney U test; p<0.05 was considered significant.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Analysis of CCR6+ Th cells in immune-competent C57BL/6 mice
###end title 30
###begin p 31
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Sallusto1">[19]</xref>
Antigen-specific T cell response occurs in distinct steps. After activation Th cells differentiate into effector cells that migrate to their target organs, and orchestrate the immune response. Therefore, re-organization of adhesion molecules and chemokine receptors is a hallmark of T cell differentiation [19].
###end p 31
###begin p 32
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 288 289 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 294 295 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 329 348 327 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g001">Fig. 1A, left panel</xref>
###xml 443 462 435 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g001">Fig. 1A, left panel</xref>
###xml 555 556 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 644 664 636 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g001">Fig. 1A, right panel</xref>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
In this study we analysed the fate and the function of CCR6+ Th cells in naive and vaccinated mice. Analysis of the cytokine pattern of lymph node residing CCR6+ Th cell fraction in naive mice showed that this T cell subpopulation clearly consists of Th17 cells; 16.1% (+/-4.7) of the CD4+ CCR6+ Th cell fraction produced IL-17 (Fig. 1A, left panel). In the respective Th cell fraction nearly no IFN-gamma production was observed (0.6%+/-0.3; Fig. 1A, left panel). In addition, neither IL-4 nor the anti-inflammatory cytokine IL-10 were detectable in CCR6+ Th cells (data not shown). Th cells that were negative for CCR6 did not produce IL-17 (Fig. 1A, right panel). The exclusive production of the cytokine IL-17 allowed us to follow the generation of Th17 cells according to the surface marker CCR6 during the immune response in our study.
###end p 32
###begin title 33
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Residual CD4+ CCR6+ T cells show an activated phenotype in C57BL/6 mice.
###end title 33
###begin p 34
###xml 207 208 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 482 483 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 488 489 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 519 520 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 525 526 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 824 825 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 829 830 823 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 851 852 845 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 856 857 850 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
(A and B) Lymph nodes of naive C57BL/6 mice were harvested and cells were analysed by multicolour flow cytometry. For each experiment lymph node cells from three mice were pooled. (A) Cells were gated on CD4+ cells and the expression of CCR6 and IL-17 or CCR6 and IFN-gamma was monitored. The percentage of cytokine producing cells in the live cell gate was determined. Data is given as mean (+/-SEM) of three independent experiments. (B) The expression of activation markers on CD4+ CCR6+ (dark grey histogram) and CD4+ CCR6- (light grey histogram) cells was analysed. Data is representative for three independent experiments. (C) OT-II mice were fed with BrdU. Cells were isolated from lymph nodes. In vivo proliferation of Th cells was assessed by their BrdU-linked fluorescence. Representative density plots of gated CD4+CCR6+ (left panel) and CD4+CCR6- (right panel) cells are shown. Data is given as mean (+/-SEM) of six independent experiments.
###end p 34
###begin p 35
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 180 187 180 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g001">Fig. 1B</xref>
###xml 329 330 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 341 348 341 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g001">Fig. 1B</xref>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 645 646 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 761 762 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 825 832 823 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g001">Fig. 1C</xref>
###xml 845 846 843 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 961 962 959 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1008 1015 1004 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g001">Fig. 1C</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
Since the CCR6+ IL-17 producing cells were present in naive mice we were interested in the phenotype of those cells. CCR6+ Th cells expressed the activation markers CD69 and CD44 (Fig. 1B) in untreated mice. In contrast to the former markers, CD62L and CD45RB are characteristics of naive Th cells and were down regulated on CCR6+ Th cells (Fig. 1B). The expression pattern of the activation markers and adhesion molecules on CCR6+ Th cells pointed to an activated phenotype of these cells in naive mice; it did not change substantially after immunisation (data not shown). To correlate the activated phenotype with functional properties on CCR6+ Th cells we determined in vivo proliferation of those cells in non-vaccinated C57BL/6 mice. In naive mice the CCR6+ Th cell subpopulation proliferated vigorously. 15.5% (+/-5.2; Fig. 1C) of the CCR6+ Th cells incorporated BrdU within the treatment period of three days. Nearly no proliferation was detected in CCR6- Th cells (0.4% cells in proliferation+/-0.2; Fig. 1C).
###end p 35
###begin title 36
Vaccination favours the development of IFN-gamma producing Th1 cells
###end title 36
###begin p 37
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 392 410 392 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g002">Fig. 2A left panel</xref>
###xml 476 477 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 520 539 520 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g002">Fig. 2B, left panel</xref>
###xml 634 654 630 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g002">Fig. 2A, right panel</xref>
###xml 699 700 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 711 731 703 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g002">Fig. 2B, right panel</xref>
###xml 1106 1113 1098 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002951.s001">Fig. S1</xref>
###xml 1212 1213 1204 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1243 1250 1235 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g002">Fig. 2C</xref>
###xml 1421 1422 1409 1410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1431 1432 1419 1420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1560 1561 1548 1549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1585 1592 1573 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g002">Fig. 2D</xref>
###xml 1679 1680 1665 1666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1791 1792 1775 1776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1850 1857 1834 1841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g001">Fig. 1C</xref>
###xml 1862 1864 1846 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g002">2D</xref>
###xml 1893 1894 1877 1878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1959 1966 1943 1950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g002">Fig. 2D</xref>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 1100 1104 <span type="species:ncbi:10090">mice</span>
###xml 1844 1848 <span type="species:ncbi:10090">mice</span>
To clarify the role of CCR6+ Th17 cells during the immune response we vaccinated C57BL/6 mice with OVA and CpG-oligodeoxynucleotides (ODN) as adjuvant. These conditions mimic the situation during infections with pathogens. During the acute phase of the T cell response on day six after vaccination lymph node cells had a reduced capacity to produce IL-17 protein after polyclonal activation (Fig. 2A left panel). As in naive animals IL-17 production was restricted to the CCR6+ Th cell subpopulation after immunisation (Fig. 2B, left panel). Following immunisation IFN-gamma became the dominant cytokine produced by lymph node cells (Fig. 2A, right panel). Thereby, IFN-gamma was synthesised by CCR6- Th cells (Fig. 2B, right panel) and cytotoxic T lymphocytes (CTL; data not shown). To rule out whether these findings are due to the use of CpG-ODN we performed additional immunisation experiments using alum and IFA as adjuvants. Both alum precipitated OVA and OVA emulsified in IFA induced the same reduction in Th17 cells during the peak phase of the immune response as seen in CpG-OVA vaccinated mice (Fig. S1). The decrease in IL-17 producing Th cells after vaccination correlated with the reduction of CCR6+ Th cells in the lymph nodes (Fig. 2C). To elucidate the mechanisms underlying the different kinetics of the induction of IL-17 and IFN-gamma, respectively, we determined the kinetics of the expansion of CCR6+ and CCR6- cells during the course of the immune response in vivo. Immunisation led to a tremendous induction of proliferation of the CCR6- Th cell subpopulation (Fig. 2D; 34.7%+/-8.6). Between days three and six of the immune reaction the expansion of CCR6- cells was almost completed and the proliferation rate dropped to 5.4% of proliferating cells (+/-2.1). As CCR6+ Th cells showed a high proliferation rate in naive mice (Fig. 1C and 2D), the responsiveness of CCR6+ Th cells to vaccination was rather weak but clearly detectable (Fig. 2D; 33.6%+/-8.4).
###end p 37
###begin title 38
Production of IL-17 and IFN-gamma is differentially regulated during the immune response.
###end title 38
###begin p 39
###xml 539 560 533 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">materials and methods</xref>
###xml 639 640 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 744 745 732 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 968 969 954 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 974 975 960 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 995 996 981 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1001 1002 987 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
(A-C) C57BL/6 mice were immunised for the indicated periods of time. For each experiment lymph node cells from three mice were pooled. (A) Cells were cultured in the presence of plate bound anti-CD3. After 72 h in culture supernatants were collected. The amounts of IL-17 (left panel) and IFN-gamma (right panel) were analysed by ELISA. ELISA was performed in duplicates. Data is given as mean (+/-SEM) of two independent experiments, * p<0.05. (B) Intracellular cytokine staining was performed immediately after isolation as described in materials and methods. The percentage of IL-17 and IFN-gamma producing cells (+/-SEM) within the CD4+ T cell fraction was determined by flow cytometry. Three independent experiments were performed. (C) CD4+ lymphocytes were analysed for the expression of CCR6. Mean values (+/-SEM) of three independent experiments are shown, * p<0.05. (D) OT-II mice were immunised for the indicated periods of time. In vivo proliferation of CD4+ CCR6+ (open bars) and CD4+ CCR6- (black bars) cells was determined according to their BrdU-linked fluorescence. Data is given as mean values (+/-SEM) of three (day 6) to six (day 0 and d 3) independent experiments. * p<0.01.
###end p 39
###begin title 40
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Antigen-specific CCR6+ Th17 cells are generated in response to OVA in C57BL/6 mice
###end title 40
###begin p 41
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 541 560 541 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g003">Fig. 3A, left panel</xref>
###xml 687 707 683 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g003">Fig. 3A, right panel</xref>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
So far we noticed proliferation of CCR6+ Th cells following immunisation with OVA and CpG-ODN but the antigen-specificity of these vaccination-induced cells still needed to be clarified. Therefore, we tested whether in vivo activated Th cells are capable to produce IL-17 in response to in vitro re-stimulation with specific antigen. Cells obtained either from naive mice or mice that were immunised for two days did not release IL-17 in response to OVA-challenge. On day six after immunisation cells produced considerable amounts of IL-17 (Fig. 3A, left panel). In accordance to polyclonal activation antigen-specific re-stimulation resulted in a strong induction of IFN-gamma release (Fig. 3A, right panel).
###end p 41
###begin title 42
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Induction of antigen-specific CCR6+ Th17 cells after vaccination.
###end title 42
###begin p 43
###xml 569 570 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 575 576 569 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
C57BL/6 mice were immunised for the indicated periods of time. Lymph node cells were isolated and stimulated in vitro. (A) OVA-stimulated (black bars) or control cells (open bars) were cultured for 72 h in vitro. The amounts of IL-17 and IFN-gamma were quantified. ELISA was performed in duplicates. Mean values (+/-SEM) of three independent experiments are depicted (n.d. indicates values below the detection limit). (B) Lymph node cells of three mice were pooled, labelled with CFSE and cultured for 96 h. Proliferation of OVA-stimulated (right panel) and control CD4+ CCR6+ cells (left panel) was determined by CFSE dilution. Each data point represents one experiment (n = 3/time point). Horizontal bars indicate the mean. * p<0.05.
###end p 43
###begin p 44
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 190 210 190 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g003">Fig. 3B, right panel</xref>
###xml 284 303 284 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g003">Fig. 3B, left panel</xref>
###xml 610 617 610 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g004">Fig. 4A</xref>
###xml 731 732 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 768 769 768 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 778 779 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 884 885 884 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 966 973 966 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g004">Fig. 4B</xref>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
We next determined the capacity of in vivo activated CCR6+ Th17 cells to expand in vitro. On day six after vaccination we detected antigen-induced proliferation of the CCR6+ Th cell subset (Fig. 3B, right panel). Cells cultured without exogenous antigen also progressed in divisions (Fig. 3B, left panel). This suggests that endogenous antigen derived from the previous vaccination induced proliferation in those cells. This hypothesis was supported by the fact that T cells obtained from mice on day 21 after immunisation did not proliferate without re-stimulation but responded to the administration of OVA (Fig. 4A). Moreover, at that late point of the immune response antigen-specific reactivity was largely limited to the CCR6+ Th cell subpopulation. Whereas CCR6+ and CCR6- Th cells proliferated to the same extent upon polyclonal stimulation only a small proportion of the CCR6- Th cell subpopulation showed responsiveness to in vitro challenge with antigen (Fig. 4B).
###end p 44
###begin title 45
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
On day 21 after immunisation CD4+ CCR6+ proliferated in response to specific antigen.
###end title 45
###begin p 46
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
C57BL/6 mice were immunised for 21 days. Lymph nodes cells of three mice were pooled for each experiment and labelled with CFSE. (A) Cells were cultured for 96 h in the absence or presence of OVA. Proliferation was measured by flow cytometry. The proportion of proliferating cells within the CD4+ CCR6+ fraction was determined. Each data point represents one experiment (n = 3/time point). Horizontal bars indicate the mean. * p<0.05. (B) Cells were stimulated with anti-CD3 or OVA and proliferation was assessed by flow cytometry. The percentage of proliferating cells is depicted. One representative experiment out of three is show.
###end p 46
###begin title 47
CCR6 defines functional antigen-specific Th17 cells that induce autoimmune disease
###end title 47
###begin p 48
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Komiyama1">[20]</xref>
###xml 493 494 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 737 738 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 749 756 749 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g005">Fig. 5A</xref>
###xml 782 783 782 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 792 793 792 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 864 865 864 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 876 883 876 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g005">Fig. 5B</xref>
###xml 939 940 939 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 944 945 944 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 978 986 978 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002951.s002">Fig. S2A</xref>
###xml 1085 1093 1085 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002951.s002">Fig. S2B</xref>
###xml 1163 1164 1163 1164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1240 1241 1240 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1364 1371 1364 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002951-g005">Fig. 5C</xref>
###xml 1376 1383 1376 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002951-t001">Table 1</xref>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 128 134 <span type="species:ncbi:10090">murine</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 1329 1333 <span type="species:ncbi:10090">mice</span>
To investigate whether CCR6 could be used as a specific marker to isolate functional Th17 cells we induced EAE in mice. In this murine model for multiple sclerosis the autoimmune deterioration of the central nervous system (CNS) is mainly mediated by inflammatory Th17 cells [20]. Antigen-specific Th cells are primed by vaccination with the myelin-specific antigen PLP. Disease is induced transferring in vivo activated lymph node cells into naive recipient mice. Therefore, depletion of CCR6+ Th cells in that particular transfer model should prevent disease development in mice. In accordance with our previous observations we observed a significant reduction of IL-17 production in PLP re-stimulated lymph node cells depleted of CCR6+ Th cells (Fig. 5A). Analysis of sorted CCR6+ and CCR6- Th cell fractions revealed that IL-17 was exclusively produced by CCR6+ Th cells (Fig. 5B). Although, lymph node cells that were depleted for CD4+CCR6+ cells regained CCR6 expression (Fig. S2A) nearly no IL-17 production was detected in those cells after in vitro re-stimulation for 3 days (Fig. S2B). Consequently, adoptive transfer of lymph node cells containing CCR6+ Th cells into naive recipients induced severe EAE whereas depletion of CCR6+ Th cells form donor cells considerably attenuated the severity of disease in recipient mice, and reduced their mortality (Fig. 5C and Table 1).
###end p 48
###begin title 49
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Depletion of CD4+ CCR6+ T cells attenuates disease development in at-EAE.
###end title 49
###begin p 50
###xml 42 63 42 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">materials and methods</xref>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 206 207 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 464 465 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 470 471 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 489 490 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 495 496 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 810 811 804 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 816 817 810 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
SJL/J mice were immunised as described in materials and methods. On day 10 lymph nodes were harvested and cells were isolated. (A) Total lymph node cells (open bar) or lymph node cells depleted of CD4+ CCR6+ cells (black bar) were cultured in vitro in the presence of PLP for 72 h. The production of IL-17 protein was quantified. ELISA was performed in duplicates. Data represents the mean values (+/-SEM) of two independent experiments. * p<0.05. (B) Purified CD4+ CCR6+ (open bar) or CD4+ CCR6- (black bar) T cells were stimulated with plate bound anti-CD3 for 72 h. IL-17 was quantified. ELISA was performed in duplicates. Data represents the mean values (+/-SEM) of three independent experiments. * p<0.05. (C) Mean EAE scores (+/-SEM) from mice received either total lymph node cells (open squares) or CD4+ CCR6+ depleted lymph node cells (closed circles) are shown (n = 5/group). The differences between the two groups were statistically significant by day 6 through day 17. * p<0.05.
###end p 50
###begin title 51
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Depletion of CD4+ CCR6+ T cells attenuates disease in the at-EAE model.
###end title 51
###begin p 52
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Clinical outcome of EAE of mice that had received either total lymph node cells or CD4+CCR6+ depleted lymph node cells is shown for the observation period of 20 days.
###end p 52
###begin p 53
Cumulative score was calculated by summing up each individual score registered during the follow-up period.
###end p 53
###begin p 54
LNC, lymph node cells
###end p 54
###begin p 55
###xml 29 33 <span type="species:ncbi:10090">mice</span>
p<0.05 compared with control mice; Mann-Whitney U test.
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Sallusto2">[21]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Kim1">[22]</xref>
###xml 230 231 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Fitzhugh1">[23]</xref>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-AcostaRodriguez1">[15]</xref>
###xml 622 623 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 692 693 692 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
Differential expression of chemokine receptors is an accepted principle for the classification of different Th cell subpopulations [21], [22]. The chemokine receptor CCR6 is expressed on activated Th cells but the function of CCR6+ Th cells has been rather obscure for a long time [23]. Recent reports on Th17 cells start to enlighten the role of this particular T cell subset [15]. In our study we demonstrated for the first time that CCR6 is a valid marker to define functional antigen-specific Th17 cells in mice. In naive and immunised mice IL-17 producing Th cells from lymph nodes exclusively resided within the CCR6+ Th cell fraction. Analysis of the cytokine production of sorted CCR6+ Th cells clearly showed that this Th cell fraction was the only source of IL-17 protein within the Th cell population.
###end p 57
###begin p 58
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Bettelli2">[24]</xref>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Matsui1">[26]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Komiyama1">[20]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Komiyama1">[20]</xref>
###xml 555 556 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 595 596 595 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 885 886 885 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 890 891 890 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 927 928 927 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1032 1033 1032 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
A common issue linking CCR6 expressing Th cells and Th17 cells is their association with autoimmune diseases [24]-[26]. IL-17 producing Th cells have been shown to be responsible for the development of EAE in mice [20]. As a matter of fact depletion of auto-reactive Th17 cells on the basis of CCR6 expression from lymph node cells attenuated the encephalitogenicity of transferred cells in at-EAE. It is important to note that IL-17 producing CTL [20] could not compensate for the loss in IL-17 producing Th cells resulting from the depletion of the CCR6+ Th cell fraction. The ablation of CCR6+ Th cells from lymph node cells of PLP immunised mice almost completely prevented IL-17 production. This experiment places emphasis on the correlation between IL-17 production and CCR6 expression. Interestingly, in vitro re-stimulation of primed lymph node cells that were depleted for CD4+CCR6+ cells, led to the emergence of CCR6+ T cells but not Th17 cells. As we were not able to completely block EAE development by deletion of CCR6+ Th17 cells, it is conceivable that those cells regain functionality in vivo irrespective of their inability to produce IL-17 during in vitro culture.
###end p 58
###begin p 59
###xml 152 155 149 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Veldhoen1">[9]</xref>
###xml 157 161 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Bettelli1">[11]</xref>
###xml 212 213 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 265 269 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Hirota2">[27]</xref>
###xml 537 540 534 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Veldhoen1">[9]</xref>
###xml 542 546 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Chen1">[28]</xref>
###xml 28 34 <span type="species:ncbi:10090">murine</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
Up to now the generation of murine Th17 cells is accomplished by polarizing these cells in vitro in the presence of cytokines such as IL-6 and TGF-beta [9], [11]. Additionally, the spontaneous development of CCR6+ Th17 cells could be shown in autoimmune prone mice [27] but the stimulatory requirements for the development of Th17 cells in the course of an infection are yet ill-defined. In vitro IL-17 production can be forced by stimulating lymph node cells with pathogenic components, such as LPS, CpG DNA motifs, and pertussis toxin [9], [28]. Those toll-like-receptor-activating substances trigger the production of pro-inflammatory cytokines by antigen presenting cells that further induce Th cell differentiation towards the Th17 subtype. Thus, our non-infectious vaccination scheme provides the opportunity to follow the formation of Th17 cells in vivo.
###end p 59
###begin p 60
###xml 554 555 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 793 797 793 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Cai1">[29]</xref>
###xml 799 803 799 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Wucherpfennig1">[30]</xref>
###xml 960 964 960 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Dorfman1">[31]</xref>
###xml 965 969 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Wucherpfennig3">[34]</xref>
###xml 1145 1149 1145 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Lohr1">[35]</xref>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
In fact, we were able to induce antigen-specific Th17 cells by our protocol. These cells were functional by producing IL-17 protein and expanding in response to their specific antigen without the presence of additional polarizing cytokines. The presence of IL-17 in antigen-specifically re-stimulated cell cultures suggested the differentiation of Th17 cells from non-committed naive T cells after vaccination. However, since Th17 cells are most abundant in naive mice we cannot completely rule out whether that cytokine is derived from pre-existing CCR6+ memory cells. This implies the presence of cross-reactive T cells within the IL-17 producing Th cell subpopulation. Polyspecific T cells are part of the normal T cell repertoire and initially selected against self- or microbial antigens [29], [30]. Although, the promiscuity in antigen recognition is thought to be in particular important for T cell memory and homeostasis it often leads to autoimmunity [31]-[34]. Indeed, IL-17 production in our experiments is accompanied with Th cells with a memory phenotype. Since those cells are resistant to suppression by regulatory T (Treg) cells [35] the occurrence of polyspecificity within the Th17 cell subset might explain the detrimental role of Th17 cells for the development of chronic inflammatory diseases.
###end p 60
###begin p 61
###xml 207 210 203 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Harrington1">[8]</xref>
###xml 813 814 809 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1034 1038 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Witowski1">[36]</xref>
###xml 1040 1044 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Fossiez1">[37]</xref>
###xml 1207 1211 1203 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Laan1">[38]</xref>
###xml 1213 1217 1209 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Ye1">[39]</xref>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
Strikingly, our data demonstrate that Th1 cells became the predominant Th cell subtype during the peak of the physiological inflammatory response. As IFN-gamma negatively regulates IL-17 production in vitro [8] this cytokine also seems to display a suppressive effect on Th17 cells in vaccinated mice. Since we observed a reduction of Th17 cells under Th1, and Th2 polarizing conditions these observations might reflect the differential temporary needs for Th1 or Th2 cells and Th17 cells during the course of an infection, and account for the different kinetics underlying the development of these Th cell subtypes. Th17 cells are equipped with homing receptors that allow them to reside in peripheral tissues. We also noticed a robust proliferation and expression of activation-induced receptors within the CCR6+ Th cell subset in non-vaccinated mice. This pointed to a Th cell subpopulation that is constantly on the alert. Th cell-derived IL-17 induces the production of growth factors, cytokines, and chemokines by stromal cells [36], [37]. Thus, Th17 cells provide the stimulatory conditions creating the appropriate environment needed for the recruitment of innate immune cells early in inflammation [38], [39]. Subsequently, during the peak of the immune response Th1 cells assume their role in promoting the functionality of CTL and macrophages.
###end p 61
###begin p 62
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Kohler1">[40]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Ambrosini1">[41]</xref>
###xml 329 332 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Lechner1">[18]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Varona1">[42]</xref>
###xml 829 833 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Kohler1">[40]</xref>
###xml 869 870 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
An open question still remains: is ligation of CCR6 required for in vivo activation of Th17 cells? Since blocking CNS-expressed CCL20, the cognate ligand of CCR6, in active EAE results in an attenuation of the disease [40], [41] CCR6 expression seems to be necessary for the generation of functional Th17 cells. Accordingly, CCR6-/- mice exhibit impaired Th cell function in delayed type of hypersensitivity reactions (DTH) and in re-infection experiments [18], [42]. These inflammatory conditions also test primed Th cells for their functionality. One likely explanation is that in those models the CCR6-mediated migration of Th cells into the target organs is needed for a sufficient activation of Th17 cells. In contrast, in the respective adoptive transfer EAE model blocking CCL20 did not prevent the development of disease [40]. That indicates once activated CCR6+ Th17 cells remain functional. They react against endogenous antigen and cause autoimmunity. Together, these findings point to a defect in the differentiation towards the Th17 subtype in the absence of CCR6.
###end p 62
###begin p 63
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Bettelli3">[43]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Kleinewietfeld1">[44]</xref>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002951-Bettelli1">[11]</xref>
From our observations, we conclude that CCR6+ Th cells represent an activated Th cell subpopulation. They are capable of producing IL-17 after vaccination with protein antigens. However, exceeded stimulation of Th17 cells results in a continuous production of IL-17 that promotes autoimmune phenomena [43]. Therefore, Th17 cells have to be controlled effectively. CCR6 is a common attribute of certain tissue homing Treg cells [44] and Th17 cells, and the dichotomy between Treg cells and inflammation-promoting Th17 cells has been stated recently [11]. Equipped with a similar type of homing and activation receptors both Th cell subtypes might meet at the sites of inflammation and cross-regulate each other. Extending the knowledge of the mechanisms influencing the generation and recruitment of Th17 cells in vivo, and the identification of additional target structures on these cells may lead to new therapeutic approaches for the treatment of autoimmune disorders or to the development of innovative vaccination strategies.
###end p 63
###begin title 64
Supporting Information
###end title 64
###begin p 65
###xml 707 708 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 738 739 730 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 942 963 934 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">materials and methods</xref>
###xml 1003 1004 995 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1025 1026 1017 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 1131 1135 <span type="species:ncbi:10090">mice</span>
###xml 1153 1157 <span type="species:ncbi:10090">mice</span>
IL-17 production is down regulated during the immune response. (A-C) C57BL/6 mice were immunised with 100 microg OVA either adsorbed to Imject(R) alum (Pierce Biotechnology, Rockford, USA) or emulsified in incomplete Freund's adjuvant (IFA). Draining lymph nodes of naive mice (black bar) and mice immunised with Ova alum (grey bars) or IFA (open bars) were harvested at the indicated time points. (A) Cells were stimulated in vitro with plate bound anti-CD3 for 72 h. The production of IL-17 protein was quantified. ELISA was performed in duplicates. * p<0.05; compared to day 0. (B) Cells were applied for intracellular cytokine staining immediately after isolation. The percentage of IL-17 producing CCR6+ cells (+/-SEM) within the CD4+ T cell fraction was determined by flow cytometry. * p<0.05; compared to day 0. (C) Intracellular cytokine staining of lymph node cells obtained on day 6 after immunisation was performed as described in materials and methods. The percentage of IL-17 producing CCR6+ cells within the CD4+ T cell fraction was determined by flow cytometry. Data represents the mean values+/-SEM (n = 3, control mice; n = 4 immunised mice).
###end p 65
###begin p 66
(0.55 MB TIF)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
###xml 135 156 135 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">materials and methods</xref>
###xml 231 232 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 237 238 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 526 547 524 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">materials and methods</xref>
###xml 572 573 570 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 578 579 576 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
CCR6 expression does not concur with IL-17 production in PLP re-stimulated lymph node cells. SJL/J mice were immunised as described in materials and methods. (A) Total lymph node cells (open bar) or lymph node cells depleted of CD4+ CCR6+ cells (black bar) were re-stimulated with PLP for 72 h in vitro. The percentage of CCR6+ cells within the CD4+ T cell fraction is shown. Data represents the mean values+/-SEM (n = 4). (B) After the 72 h re-stimulation period intracellular cytokine staining was performed as described in materials and methods. Cells were gated on CD4+ CCR6+ cells and the percentage of IL-17 producing cells was calculated. Data is given as mean+/-SEM (n = 4; * p<0.05).
###end p 68
###begin p 69
(0.21 MB TIF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
The authors would like to thank Prof. W. Falk for critical discussions on our work and Drs. M. Windbichler and S. Mostbock for carefully reviewing the manuscript.
###end p 71
###begin title 72
References
###end title 72
###begin article-title 73
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.
###end article-title 73
###begin article-title 74
###xml 46 51 <span type="species:ncbi:9606">human</span>
Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory T cells.
###end article-title 74
###begin article-title 75
###xml 89 110 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.
###end article-title 75
###begin article-title 76
IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available.
###end article-title 76
###begin article-title 77
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.
###end article-title 77
###begin article-title 78
Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.
###end article-title 78
###begin article-title 79
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.
###end article-title 79
###begin article-title 80
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.
###end article-title 80
###begin article-title 81
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.
###end article-title 81
###begin article-title 82
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells.
###end article-title 82
###begin article-title 83
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
###end article-title 83
###begin article-title 84
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.
###end article-title 84
###begin article-title 85
###xml 120 125 <span type="species:ncbi:9606">human</span>
Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells.
###end article-title 85
###begin article-title 86
Invasion, control and persistence of Leishmania parasites.
###end article-title 86
###begin article-title 87
###xml 47 52 <span type="species:ncbi:9606">human</span>
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.
###end article-title 87
###begin article-title 88
Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.
###end article-title 88
###begin article-title 89
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
###end article-title 89
###begin article-title 90
###xml 93 109 <span type="species:ncbi:5664">Leishmania major</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
Protective immunity and delayed type hypersensitivity reaction are uncoupled in experimental Leishmania major infection of CCR6-negative mice.
###end article-title 90
###begin article-title 91
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.
###end article-title 91
###begin article-title 92
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.
###end article-title 92
###begin article-title 93
Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells.
###end article-title 93
###begin article-title 94
Rules of chemokine receptor association with T cell polarization in vivo.
###end article-title 94
###begin article-title 95
Cutting edge: C-C chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro.
###end article-title 95
###begin article-title 96
Th17: the third member of the effector T cell trilogy.
###end article-title 96
###begin article-title 97
Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.
###end article-title 97
###begin article-title 98
Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis.
###end article-title 98
###begin article-title 99
T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.
###end article-title 99
###begin article-title 100
Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells.
###end article-title 100
###begin article-title 101
Multispecific responses by T cells expanded by endogenous self-peptide/MHC complexes.
###end article-title 101
###begin article-title 102
Polyspecificity of T cell and B cell receptor recognition.
###end article-title 102
###begin article-title 103
MHC-dependent survival of naive T cells? A complicated answer to a simple question.
###end article-title 103
###begin article-title 104
A role for TCR affinity in regulating naive T cell homeostasis.
###end article-title 104
###begin article-title 105
###xml 75 80 <span type="species:ncbi:9606">human</span>
Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.
###end article-title 105
###begin article-title 106
###xml 36 41 <span type="species:ncbi:9606">human</span>
Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide.
###end article-title 106
###begin article-title 107
Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease.
###end article-title 107
###begin article-title 108
IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells.
###end article-title 108
###begin article-title 109
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.
###end article-title 109
###begin article-title 110
###xml 26 31 <span type="species:ncbi:9606">human</span>
Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways.
###end article-title 110
###begin article-title 111
###xml 45 66 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Interleukin-17 and lung host defense against Klebsiella pneumoniae infection.
###end article-title 111
###begin article-title 112
A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system.
###end article-title 112
###begin article-title 113
Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro.
###end article-title 113
###begin article-title 114
###xml 15 19 <span type="species:ncbi:10090">mice</span>
CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses.
###end article-title 114
###begin article-title 115
T(H)-17 cells in the circle of immunity and autoimmunity.
###end article-title 115
###begin article-title 116
CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset.
###end article-title 116
###begin p 117
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 117
###begin p 118
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a project grant of the Deutsche Forschungsgemeinschaft (LE 2435/1-1 to AL) and an intramural ReForM grant of the Medical Faculty of the University of Regensburg. A scholarship of the Bayerische Forschungsstiftung was granted to JP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 118

